Farside CV relabelling [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2010-11-09 16:10 (5301 d 21:19 ago) – Posting: # 6121
Views: 13,879

Dear D. Labes!

❝ ❝ Well, I have no idea what Pharsight calculated here …


❝ Me too. Their formula given on the slide

  +1.25(sigmaRef/0.25)

❝ is clearly nonsense. It would give negative lower bounds!


Sure. But note that the upper bound is OK, maybe the have calculated L=1/U?

❝ The correct one is

  exp(+log(1.25)*sigmaRef/0.25)

❝ I think.


Right – as always. :cool:

❝ Taking the numbers for the widened acceptance ranges given, they seems to have a label problem.


Oh no! :crying:

❝ Eventually one should remind the author of the slides that labelling falls under the policy of GMP :-D.


I have linked this thread to Pharsight’s Extranet ten hours ago…

❝ BTW:

<nitpicking> ------------------

❝ I get for the FDA's widened limits: [...]


</nitpicking> ------------------


Me too – even with bloody M$-Excel (excuse me, Martin). Don’t know what László has done here. Was too late to produce a nice looking plot in R

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
159 visitors (0 registered, 159 guests [including 18 identified bots]).
Forum time: 14:29 CEST (Europe/Vienna)

A statistical analysis, properly conducted, is a delicate dissection of
uncertainties, a surgery of suppositions.    Micheal J. Moroney

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5